Thrivent Financial for Lutherans’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $242K | Sell |
7,942
-178
| -2% | -$5.42K | ﹤0.01% | 2356 |
|
2025
Q1 | $219K | Sell |
8,120
-425
| -5% | -$11.5K | ﹤0.01% | 2302 |
|
2024
Q4 | $307K | Sell |
8,545
-133
| -2% | -$4.78K | ﹤0.01% | 2406 |
|
2024
Q3 | $329K | Sell |
8,678
-495
| -5% | -$18.8K | ﹤0.01% | 2368 |
|
2024
Q2 | $415K | Sell |
9,173
-452
| -5% | -$20.4K | ﹤0.01% | 2289 |
|
2024
Q1 | $467K | Sell |
9,625
-262
| -3% | -$12.7K | ﹤0.01% | 2260 |
|
2023
Q4 | $530K | Sell |
9,887
-354
| -3% | -$19K | ﹤0.01% | 2193 |
|
2023
Q3 | $600K | Sell |
10,241
-466
| -4% | -$27.3K | ﹤0.01% | 2049 |
|
2023
Q2 | $675K | Sell |
10,707
-332
| -3% | -$20.9K | ﹤0.01% | 2044 |
|
2023
Q1 | $694K | Sell |
11,039
-387
| -3% | -$24.3K | ﹤0.01% | 1987 |
|
2022
Q4 | $608K | Sell |
11,426
-84
| -0.7% | -$4.47K | ﹤0.01% | 2028 |
|
2022
Q3 | $645K | Buy |
11,510
+199
| +2% | +$11.2K | ﹤0.01% | 1942 |
|
2022
Q2 | $818K | Buy |
11,311
+1,805
| +19% | +$131K | ﹤0.01% | 1831 |
|
2022
Q1 | $755K | Buy |
9,506
+3
| +0% | +$238 | ﹤0.01% | 1984 |
|
2021
Q4 | $962K | Sell |
9,503
-203
| -2% | -$20.6K | ﹤0.01% | 1883 |
|
2021
Q3 | $895K | Buy |
9,706
+276
| +3% | +$25.5K | ﹤0.01% | 1887 |
|
2021
Q2 | $966K | Sell |
9,430
-334
| -3% | -$34.2K | ﹤0.01% | 1868 |
|
2021
Q1 | $953K | Sell |
9,764
-168
| -2% | -$16.4K | ﹤0.01% | 1905 |
|
2020
Q4 | $766K | Hold |
9,932
| – | – | ﹤0.01% | 1930 |
|
2020
Q3 | $731K | Sell |
9,932
-270
| -3% | -$19.9K | ﹤0.01% | 1758 |
|
2020
Q2 | $749K | Sell |
10,202
-318
| -3% | -$23.3K | ﹤0.01% | 1697 |
|
2020
Q1 | $608K | Buy |
10,520
+525
| +5% | +$30.3K | ﹤0.01% | 1610 |
|
2019
Q4 | $785K | Sell |
9,995
-262
| -3% | -$20.6K | ﹤0.01% | 1621 |
|
2019
Q3 | $701K | Sell |
10,257
-142
| -1% | -$9.71K | ﹤0.01% | 1640 |
|
2019
Q2 | $826K | Buy |
+10,399
| New | +$826K | ﹤0.01% | 1532 |
|